Xiaozhen Liu1, Kewang Sun1, Hongjian Yang2

  • 1General Surgery, Cancer Center, Department of Breast Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, 310014, China.

Heliyon
|February 29, 2024
PubMed
概括

这项研究确定了关键的溶酶体相关基因 (LRG),以预测乳腺癌的预后和治疗反应. 一个基于LRG的新型风险模型有助于个性化治疗策略,以获得更好的患者结果.